Latest 10-Q quarterly reports

Berto Acquisition Corp. II, a SPAC, reported its financial results for the second quarter ended June 30, 2026, detailing its IPO proceeds and ongoing search for a business combination.

BioNexus Gene Lab Corp. filed its Q2 2026 report, detailing a substantial decrease in revenue and continued operational losses, while also addressing internal control deficiencies and strategic initiatives.

Berto Acquisition Corp. reported a net income of $1.11 million for Q2 2026, driven by investment income, while continuing its search for a business combination.

Bone Biologics Corporation's Q2 2026 Form 10-Q highlights ongoing net losses and a substantial accumulated deficit, raising concerns about its ability to continue as a going concern despite recent capital raises.

Axe Compute Inc. reported a significant increase in revenue for Q2 2026, driven by its Compute Services segment, but also disclosed substantial net losses and increased operating expenses.

Helix Acquisition Corp. III reports net income driven by trust account interest, with ongoing efforts to identify a business combination within its 24-month window.

Mountain Crest Acquisition Corp. V's Q2 2026 Form 10-Q reveals significant challenges, including Nasdaq delisting and continued uncertainty regarding its business combination, alongside a net loss for the period.

PetVivo Holdings reported increased revenues for Q1 2027, but faces substantial doubt regarding its ability to continue as a going concern due to ongoing net losses and accumulated deficit.

HealthLynked Corp. reported a significant decline in revenue for the second quarter of 2026, with patient service revenue down 60% and a widening net loss, raising concerns about its going concern status.

Liminatus Pharma, Inc. filed its Q2 2026 Form 10-Q, detailing continued operational losses, a substantial accumulated deficit, and ongoing efforts to regain Nasdaq listing compliance.

FiEE, Inc. showcases substantial revenue growth driven by its strategic shift to SaaS and digital services, alongside acquisitions, while addressing ongoing financial and internal control challenges.

Bally's Corporation filed its Form 10-Q for the quarter ended June 30, 2026, reporting increased revenue but a substantial net loss and ongoing liquidity challenges.

Stemtech Corporation's Q2 2026 Form 10-Q reveals a significant decline in net sales and continued net losses, highlighting ongoing financial pressures and operational constraints.

Elutia Inc. reports Q2 2026 results marked by continued net losses, a potential Nasdaq delisting, and significant litigation expenses, alongside progress in strategic divestitures and new financing.

Interactive Strength Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing significant revenue growth driven by acquisitions but also highlighting substantial net losses, high debt levels, and material weaknesses in internal controls.

PSB Financial, Inc. reported a net loss of $148,413 for the three months ended June 30, 2026, following its conversion to a stock form of organization.

Jupiter Neurosciences reported a net loss of $4.34 million for the first half of 2026, with ongoing concerns about its ability to continue as a going concern, despite a new licensing agreement for ALA-002.

Brainstorm Cell Therapeutics Inc. reported continued operating losses and a substantial accumulated deficit in its Q2 2026 filing, highlighting ongoing capital needs and challenges following its Nasdaq delisting.

Vynleads, Inc. filed its Form 10-Q for the period ended June 30, 2026, revealing persistent operating losses, a growing accumulated deficit, and significant concerns about its ability to continue as a going concern.

InspireMD reports increased net loss and substantial doubt about its ability to continue as a going concern, exacerbated by a product recall and Nasdaq listing concerns.

Bold Eagle Acquisition Corp. reports substantial doubt about its ability to continue as a going concern as its business combination deadline approaches, despite generating interest income.

FutureCrest Acquisition Corp. reports on its financial condition and operational status for the quarter ended June 30, 2026, detailing its ongoing search for a business combination.

BioLargo, Inc. announced its Q2 2026 financial results, revealing a significant decrease in revenue and a widening net loss, alongside a negative working capital position.

Star Equity Holdings, Inc. reported a net loss of $1.8 million for the three months ended June 30, 2026, an increase from $0.7 million in the prior year, despite a significant rise in revenue driven by acquisitions.

New Era Energy & Digital, Inc. (NUAI) filed an amendment to its Q1 2026 Form 10-Q to restate financial statements due to accounting errors in stock compensation and expense classification, revealing material weaknesses in internal controls.

Flag Ship Acquisition Corporation filed its Q2 2026 10-Q, detailing its ongoing search for a business combination, financial status, and operational updates, while facing going concern uncertainties.

Dawson Geophysical Company's Q2 2026 results show a substantial increase in revenues and improved operational metrics, driven by large-channel-count projects and new technology deployment.

Chain Bridge I's latest quarterly report reveals a significant working capital deficit and continued uncertainty regarding its business combination, raising substantial doubt about its ability to continue as a going concern.

Northwest Biotherapeutics Inc. filed its Form 10-Q for the quarter ended June 30, 2026, detailing ongoing clinical trial efforts, significant operating losses, and substantial doubt regarding its ability to continue as a going concern.

Forum Markets, Inc. (formerly ETHZilla Corporation) filed its Form 10-Q for the quarter ended June 30, 2026, detailing a strategic pivot towards digital assets and RWA tokenization, reporting significant net losses and operational changes.